Park Avenue Securities LLC Spring Works Therapeutics, Inc. Transaction History
Park Avenue Securities LLC
- $9.72 Billion
- Q4 2024
A detailed history of Park Avenue Securities LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 5,631 shares of SWTX stock, worth $195,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,631Holding current value
$195,001% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
239Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$232 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$195 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$133 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$122 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$118 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.16B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...